-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes Agios Pharmaceuticals at Buy, Announces Price Target of $55

Benzinga·10/29/2026 13:16:55
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao assumes Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy rating and announces Price Target of $55.